-
r37980778c78--1f6ca501864d48b1fb5e145a51aa8584
Non-serious adverse events reported by participants in the two treatment groups. -
r37980778c78--c6dbafe05a78b78bac943570556d35c9
BackgroundThe metabolic activity of endogenous nitric oxide (NO) and the medical use of nitrovasodilatory drugs like isosorbide dinitrate have been shown to be potential...
